Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Syndax Pharmaceuticals Inc | d322633d10k.htm |
| EX-32.1 - EX-32.1 - Syndax Pharmaceuticals Inc | d322633dex321.htm |
| EX-31.2 - EX-31.2 - Syndax Pharmaceuticals Inc | d322633dex312.htm |
| EX-31.1 - EX-31.1 - Syndax Pharmaceuticals Inc | d322633dex311.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement No. 333-210412 on Form S-8 of our report dated March 14, 2017, relating to the financial statements of Syndax Pharmaceuticals, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Syndax Pharmaceuticals, Inc. for the year ended December 31, 2016.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 14, 2017